1. < Home

neuropeptide Y

Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn Reduce NPY levels via muscarinic receptor activation

Jani NR, van Weperen VYH, Ayagama T, Hoang JD, Emamimeybodi M, Bussmann BM, Bal S, Kumar A, Khaky A, Hamon D, Herring N, Smith C,[...]

By afschroeder • October 7, 2025
The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders

Zaglia T, Ajijola OA. The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders. JACC Clin Electrophysiol. 2025 Feb 24:S2405-500X(25)00068-4. doi: 10.1016/j.jacep.2025.01.012.[...]

By sjmartinez • March 17, 2025
Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β-adrenergic receptors

van Weperen VYH, Hoang JD, Jani NR, Khaky A, Herring N, Smith C, Vaseghi M. Circulating noradrenaline leads to release of neuropeptide Y from cardiac[...]

By sjmartinez • February 14, 2024